3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Hematologic Neoplasms
2
Sunburn
1
Skin Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Mucositis
1
Lymphoma
1
Head and Neck Neoplasms
1
Fallopian Tube Neoplasms
1
Colorectal Neoplasms
1
Cigarette Smoking-Related Carcinoma
1
Chronic Pain
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma in Situ
1
Brenner Tumor
1
Breast Neoplasms
1
Arthralgia
1
Anatomic Stage I Breast Cancer AJCC v8
1
Abnormalities, Radiation-Induced
1
Interventions
Dacarbazine
4
pembrolizumab
3
binimetinib
3
Nivolumab
3
encorafenib
2
cemiplimab
2
Sirolimus
2
Ipilimumab
2
vitespin
1
trametinib
1
tilsotolimod
1
spartalizumab
1
oblimersen
1
linrodostat
1
lifileucel
1
gp100 Melanoma Antigen
1
dabrafenib
1
bempegaldesleukin
1
aldesleukin
1
Vinblastine
1
Vemurafenib
1
Tretinoin
1
Tacrolimus
1
Standard of Care
1
Sodium Chloride
1
Radiotherapy
1
Radiation
1
Interleukin-2
1
Interferon-alpha
1
Interferon alpha-2
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Skin Neoplasms
×
Educational Status
×
Clear all
NCT05634252
2024-12-13
RISE-UP
University of Utah
Phase 3
Recruiting
528 enrolled